In 2006 and 2008, two live-attenuated vaccines, RotaTeq
(Merck, Whitehouse Station, NJ, USA) and Rotarix (GlaxoSmithKline, Rixensart, Belgium), respectively, were introduced in the United States (4).
And also for these agents: - Fluzone/Vaxigrip - Hepatitis group, GSK - Zostavax - Pneumovax-23 - RotaTeq
Bovine serum finds application in the production of vaccines such as MMR II, Zostavax, Varivax, and RotaTeq
, which falls in the range of below 1ppm.
The TGA, working in collaboration with state health authorities, has completed an investigation into the association between the use of the rotavirus vaccines Rotarix (GSK) and RotaTeq
(Merck/CSL) and the occurrence of a rare form of bowel obstruction known as intussusception (IS).
Rotavirus vaccines are currently available in oral drops of two or three doses, and costs from Dh255 per dose for Rotarix (two doses) and Dh273 per dose for RotaTeq
Major reduction of rotavirus gastroenteritis cases seen in hospital after introduction of RotaTeq
vaccine into National Immunization Program of Finland.
The story gets better: Regulators withdrew Rotarix from the market, in part, because of the availability of an alternative vaccine, Rotateq
, produced by Merck.
PESHAWAR, May 22 -- The US Food and Drug Administration (FDA) on May 14 revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and determined that it was appropriate for healthcare professionals to resume the use of Rotarix and to continue the use of RotaTeq
, says a press release issued on Friday.
The study said the changes in rotavirus activity may be due to the RotaTeq
vaccine introduced in 2006 and recommended for routine immunization of infants at 2, 4 and 6 months of age.
Merck already markets a similar product, Rotateq
, which is given in three injections over the course of four months.
However, while Wyeth's Prevnarand Merck & Co's Gardasil have experienced a rapid uptake driven by obvious medical need and public attention, othervaccines such as Merck & Co's RotaTeq
have failed to achieve widespread integration into routine vaccination schedules due to an unfavourable cost-benefit profile.
All infants born in Nicaragua in a three-year period will receive free doses of ROTATEQ
(rotavirus vaccine, live, oral, pentavalent), Merck's oral, ready-to-use vaccine to prevent rotavirus gastroenteritis in infants and young children when given in a three-dose series to infants between the ages of six to 32 weeks.